Common ground?: Tetracyclines, matrix metalloproteinases, pustular dermatoses, and loxoscelism

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1284-1286

  King Jr , Lloyd E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DAPSONE; MATRIX METALLOPROTEINASE; SPHINGOMYELIN PHOSPHODIESTERASE; TETRACYCLINE DERIVATIVE;

DERMATITIS HERPETIFORMIS; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG SAFETY; ENVENOMATION; HEMOLYSIS; HUMAN; HYPERBARIC OXYGEN; IN VITRO STUDY; IN VIVO STUDY; LEPROSY; LOXOSCELISM; NONHUMAN; PRIORITY JOURNAL; PUSTULE; RABBIT; REVIEW; SEROLOGY; SPIDER;

EID: 34248523572     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700724     Document Type: Note

References (12)

1. Binford GJ, Wells MA (2003) The phylogenetic distribution of sphingomyelinase D activity in venoms of Haplogyne spiders. Comp Biochem Physiol B Biochem Mol Biol 135:25-33
2. Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, et al. (2002) Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol 20:153-9
3. Gates CA, Rees RS (1990) Serum amyloid P component: its role in platelet activation stimulated by sphingomylenase D purified from the venom of the brown recluse spider (Loxosceles reclusa). Toxicon 28:1303-15
4. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I (eds) (2002) Treatment of Skin Disease: Comprehensive Therapeutic Strategies. Mosby-Elsevier: London
5. Norden PS, Phillips TJ (2005) Brown Recluse spider bite: a rare cause of necrotic wounds. Wounds 17:304-12
6. Paixão-Cavalcante D, van den Berg CW, Gonçalves-de-Andrade RM, Fernandes-Pedrosa M de F, Okamoto CK, Tambourgi DV (2007) Tetracycline protects against dermonecrosis induced by Loxosceles spider venom. J Invest Dermatol 127:1410-18
7. Patel KD, Modur V, Zimmerman GA, Prescott SM, McIntyre TM (1994) The necrotic venom of the Brown Recluse spider induces dysregulated endothelial cell-dependent neutrophil activation: differential induction of GM-CSF, IL-8, and E-selectin expression. J Clin Invest 94:631-42
8. Sams HH, Hearth SB, Long LL, Wilson DC, Sanders DH, King LE Jr. (2001) Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol 44:603-8
9. Swanson DL, Vetter RS. (2005) Bites of Brown Recluse spiders and suspected necrotic arachnidism. N Engl J Med 352:700-7
10. Tambourgi DV, Morgan BP, Goncalves-de-Andrade RM, Magnoli FC, van den Berg CW (2000) Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleaving of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis. Blood 95:683-91
11. Truett AP III, King LE Jr (1993) Sphingomyelinase D: a pathogenic agent produced by bacteria and arthropods. In: Sphingolipids: Regulation and Function of Metabolism, Advances in Lipid Research (Bell RM, Hannun YA, Merrill AH Jr, eds), Vol 26B, Academic Press: San Diego, 275-91
12. Van den Berg CW, Goncalves-de-Andrade RM, Magnoli FC, Marchbank KJ, Tambourgi DV (2002) Loxosceles spider venom induces metalloproteinases mediated cleavage of MCP/CD46 and MHC I and induces protection again C-mediated lysis. Immunology 107:102-10